CureMetrix

CureMetrix’s research is focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis technology that radiologists and patients can confidently rely on. It is committed to the advancement of technology that will improve cancer survival rates worldwide.

Currently, CureMetrix is honing their powerful image analysis platform into an adjunct, precision tool for mammography. Its goal is to equip radiologists with the objective, data-driven answers they need to support patients and their healthcare team as they make decisions about breast cancer screening, treatment and diagnosis. CureMetrix believes that providing radiologists with the most advanced technology to support their evaluation of mammograms will lead to improved clinical outcomes, reduced healthcare costs and increased assurance that patients are getting the highest standard of care available from screening through post-biopsy follow-up. CureMetrix products are CM Triage, CM Assist and CM Audit.

CureMetrix cmAssist is an investigational, computer-aided detection (CAD) software that has the potential to quickly detect key regions of interest on a mammogram, and accurately quantify and classify the anomalies as suspicious or verifiably benign.

CureMetrix cmTriage is a workflow optimization tool that enables a radiologist to customize their mammography worklist based on cases that may need immediate attention and CMAudit is designed to provide a confidential and independent analysis of your mammography performance based on your historical data. To support its efforts, CureMetrix has partnered with esteemed institutions such as University of California, San Diego, MD Anderson Cancer Center, Hoag Health Network and Johns Hopkins University to train and validate their algorithm’s ability to recognize different types of anomalies.